Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histiocytic Sarcoma | 2 | 2021 | 40 | 1.410 |
Why?
|
Hodgkin Disease | 8 | 2023 | 1378 | 0.950 |
Why?
|
Oximes | 1 | 2020 | 303 | 0.610 |
Why?
|
Preleukemia | 1 | 2017 | 34 | 0.600 |
Why?
|
Iris Diseases | 1 | 2017 | 37 | 0.580 |
Why?
|
Pyrimidinones | 1 | 2020 | 385 | 0.570 |
Why?
|
Pigmentation Disorders | 1 | 2017 | 105 | 0.560 |
Why?
|
Fetal Macrosomia | 1 | 2017 | 141 | 0.550 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 382 | 0.530 |
Why?
|
Critical Pathways | 1 | 2019 | 474 | 0.490 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2019 | 1551 | 0.490 |
Why?
|
Pyridones | 1 | 2020 | 809 | 0.470 |
Why?
|
Imidazoles | 1 | 2020 | 1180 | 0.450 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2057 | 0.440 |
Why?
|
Sarcoma | 2 | 2021 | 1801 | 0.430 |
Why?
|
Rhabdomyosarcoma, Embryonal | 4 | 2015 | 100 | 0.420 |
Why?
|
Burkitt Lymphoma | 2 | 2013 | 335 | 0.390 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1052 | 0.390 |
Why?
|
Rhabdomyosarcoma | 5 | 2014 | 358 | 0.390 |
Why?
|
Outpatients | 1 | 2019 | 1597 | 0.370 |
Why?
|
Mutation, Missense | 1 | 2020 | 2571 | 0.360 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2021 | 11742 | 0.350 |
Why?
|
Inpatients | 1 | 2019 | 2548 | 0.290 |
Why?
|
Lymphatic Diseases | 1 | 2008 | 320 | 0.260 |
Why?
|
Radiotherapy, Conformal | 2 | 2011 | 548 | 0.250 |
Why?
|
Lymphoproliferative Disorders | 2 | 2016 | 531 | 0.250 |
Why?
|
Orbital Neoplasms | 2 | 2005 | 222 | 0.250 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2010 | 491 | 0.240 |
Why?
|
Lymphoma | 3 | 2023 | 1901 | 0.240 |
Why?
|
Irritable Mood | 1 | 2024 | 194 | 0.220 |
Why?
|
Germinoma | 1 | 2003 | 132 | 0.200 |
Why?
|
Child, Preschool | 21 | 2024 | 42232 | 0.190 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3615 | 0.190 |
Why?
|
Mediastinum | 1 | 2003 | 266 | 0.190 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.190 |
Why?
|
Neuroblastoma | 2 | 2024 | 1250 | 0.180 |
Why?
|
Lymphatic Irradiation | 1 | 2021 | 115 | 0.180 |
Why?
|
Medical Order Entry Systems | 1 | 2006 | 521 | 0.180 |
Why?
|
Child | 28 | 2024 | 80158 | 0.170 |
Why?
|
Mediastinal Neoplasms | 1 | 2003 | 401 | 0.170 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2016 | 612 | 0.170 |
Why?
|
Trisomy | 1 | 2021 | 260 | 0.170 |
Why?
|
Herpesvirus 4, Human | 2 | 2021 | 1078 | 0.160 |
Why?
|
Jaundice | 1 | 2019 | 94 | 0.160 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 226 | 0.160 |
Why?
|
Hospitalization | 1 | 2019 | 10721 | 0.160 |
Why?
|
Platelet Count | 1 | 2002 | 781 | 0.160 |
Why?
|
Platelet Transfusion | 1 | 2002 | 298 | 0.160 |
Why?
|
Fever of Unknown Origin | 1 | 2019 | 94 | 0.160 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2021 | 359 | 0.160 |
Why?
|
Disease-Free Survival | 7 | 2021 | 6815 | 0.150 |
Why?
|
Drug Substitution | 1 | 2021 | 290 | 0.150 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2014 | 801 | 0.150 |
Why?
|
Sarcoma, Myeloid | 1 | 2018 | 51 | 0.150 |
Why?
|
Adolescent | 22 | 2024 | 88326 | 0.140 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.140 |
Why?
|
Exophthalmos | 1 | 2018 | 97 | 0.140 |
Why?
|
Sphenoid Bone | 1 | 2018 | 177 | 0.140 |
Why?
|
Infant | 14 | 2024 | 36193 | 0.140 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1998 | 147 | 0.140 |
Why?
|
Lymph Nodes | 4 | 2021 | 3465 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1374 | 0.130 |
Why?
|
Biopsy | 5 | 2012 | 6766 | 0.130 |
Why?
|
Blood Cell Count | 3 | 2019 | 397 | 0.130 |
Why?
|
Liver Diseases | 1 | 2024 | 1297 | 0.130 |
Why?
|
Meningeal Neoplasms | 3 | 2015 | 1248 | 0.130 |
Why?
|
Dacryocystitis | 1 | 2016 | 68 | 0.130 |
Why?
|
Gynecomastia | 1 | 2016 | 87 | 0.130 |
Why?
|
Diagnosis, Differential | 9 | 2024 | 12973 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1739 | 0.120 |
Why?
|
Dyskeratosis Congenita | 1 | 2015 | 73 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 940 | 0.120 |
Why?
|
Fever | 3 | 2018 | 1618 | 0.120 |
Why?
|
Male | 38 | 2024 | 360846 | 0.120 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2015 | 58 | 0.120 |
Why?
|
Humans | 49 | 2024 | 761596 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 592 | 0.110 |
Why?
|
Medical Oncology | 1 | 2006 | 2321 | 0.110 |
Why?
|
Combined Modality Therapy | 7 | 2019 | 8527 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2002 | 1182 | 0.110 |
Why?
|
Radiotherapy Dosage | 6 | 2024 | 2898 | 0.110 |
Why?
|
Immunoglobulin M | 1 | 1998 | 1526 | 0.110 |
Why?
|
Nasal Cavity | 1 | 2015 | 304 | 0.100 |
Why?
|
Medulloblastoma | 1 | 2018 | 678 | 0.100 |
Why?
|
Nose Neoplasms | 1 | 2015 | 249 | 0.100 |
Why?
|
Pancreatic Neoplasms | 1 | 2010 | 5368 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1609 | 0.100 |
Why?
|
Pelvic Neoplasms | 1 | 2014 | 247 | 0.100 |
Why?
|
Thoracic Neoplasms | 1 | 2014 | 267 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2057 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 547 | 0.100 |
Why?
|
Organs at Risk | 2 | 2011 | 359 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9280 | 0.090 |
Why?
|
Appendiceal Neoplasms | 1 | 2013 | 155 | 0.090 |
Why?
|
Neoplasms | 4 | 2023 | 22173 | 0.090 |
Why?
|
Whole Body Imaging | 1 | 2012 | 283 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2002 | 2330 | 0.090 |
Why?
|
Melanoma | 2 | 2019 | 5709 | 0.080 |
Why?
|
Hemorrhage | 1 | 2002 | 3424 | 0.080 |
Why?
|
Autoantibodies | 1 | 1998 | 2118 | 0.080 |
Why?
|
Fractures, Compression | 1 | 2011 | 131 | 0.080 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5821 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1922 | 0.080 |
Why?
|
Female | 26 | 2024 | 392705 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2279 | 0.080 |
Why?
|
Hypercalcemia | 1 | 2011 | 423 | 0.070 |
Why?
|
Doxorubicin | 4 | 2015 | 2224 | 0.070 |
Why?
|
Lumbar Vertebrae | 2 | 2011 | 1879 | 0.070 |
Why?
|
Treatment Outcome | 13 | 2021 | 64685 | 0.070 |
Why?
|
Breast | 1 | 2016 | 1967 | 0.070 |
Why?
|
Lymphadenitis | 1 | 2008 | 99 | 0.070 |
Why?
|
Blood Sedimentation | 1 | 2008 | 235 | 0.070 |
Why?
|
Vincristine | 2 | 2015 | 1036 | 0.070 |
Why?
|
Photons | 2 | 2011 | 589 | 0.070 |
Why?
|
Prednisone | 3 | 2012 | 1563 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.060 |
Why?
|
Cyclophosphamide | 3 | 2015 | 2220 | 0.060 |
Why?
|
Radiotherapy | 3 | 2011 | 1498 | 0.060 |
Why?
|
Organizational Case Studies | 1 | 2006 | 301 | 0.060 |
Why?
|
Abdomen | 2 | 2024 | 1128 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2018 | 20568 | 0.060 |
Why?
|
Back Pain | 2 | 2011 | 545 | 0.060 |
Why?
|
Spinal Fractures | 1 | 2011 | 705 | 0.060 |
Why?
|
Radiography | 3 | 2011 | 6965 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2015 | 1784 | 0.060 |
Why?
|
Radiotherapy, High-Energy | 1 | 2004 | 228 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12723 | 0.050 |
Why?
|
Pediatrics | 1 | 2018 | 3589 | 0.050 |
Why?
|
Protons | 3 | 2014 | 1116 | 0.050 |
Why?
|
Mastitis, Bovine | 1 | 2002 | 10 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5672 | 0.050 |
Why?
|
Switzerland | 1 | 2023 | 324 | 0.050 |
Why?
|
Phenylbutyrates | 1 | 2002 | 72 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3514 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39106 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 1008 | 0.050 |
Why?
|
Hospitals, General | 1 | 2006 | 798 | 0.050 |
Why?
|
Leukopenia | 1 | 2002 | 213 | 0.050 |
Why?
|
Uremia | 1 | 2002 | 201 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2024 | 80647 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8466 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 337 | 0.040 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2015 | 1660 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2894 | 0.040 |
Why?
|
Fetal Hemoglobin | 1 | 2002 | 345 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7528 | 0.040 |
Why?
|
Mutation | 2 | 2021 | 30053 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 978 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 155 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2002 | 15633 | 0.040 |
Why?
|
Milk | 1 | 2002 | 443 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2009 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2023 | 606 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2002 | 694 | 0.040 |
Why?
|
Serum Albumin | 1 | 2002 | 672 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2023 | 803 | 0.040 |
Why?
|
Abdominal Pain | 2 | 2016 | 1071 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2010 | 2223 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1088 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 36426 | 0.040 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2003 | 491 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 617 | 0.040 |
Why?
|
Ultrasonography | 2 | 2024 | 5971 | 0.040 |
Why?
|
Prognosis | 4 | 2023 | 29629 | 0.040 |
Why?
|
Vinblastine | 2 | 2012 | 488 | 0.040 |
Why?
|
Tumor Burden | 2 | 2015 | 1892 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1479 | 0.040 |
Why?
|
Massachusetts | 2 | 2011 | 8833 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59260 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2000 | 497 | 0.030 |
Why?
|
Age Factors | 3 | 2018 | 18399 | 0.030 |
Why?
|
Pallor | 1 | 2016 | 5 | 0.030 |
Why?
|
Cholestasis | 1 | 2019 | 378 | 0.030 |
Why?
|
Disease Progression | 3 | 2021 | 13510 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 1998 | 349 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2000 | 1596 | 0.030 |
Why?
|
Cyclosporine | 1 | 1998 | 778 | 0.030 |
Why?
|
Adult | 7 | 2019 | 221210 | 0.030 |
Why?
|
Topotecan | 1 | 2015 | 132 | 0.030 |
Why?
|
Bacteremia | 1 | 2002 | 980 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3600 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2000 | 1125 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2019 | 732 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2002 | 15266 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 523 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2002 | 1063 | 0.030 |
Why?
|
Ultrasonography, Mammary | 1 | 2016 | 239 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2693 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1998 | 664 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3306 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1998 | 1835 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 634 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2295 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2012 | 11120 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2000 | 1768 | 0.030 |
Why?
|
Colon, Sigmoid | 1 | 2013 | 124 | 0.030 |
Why?
|
Brain | 3 | 2015 | 27121 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1958 | 0.030 |
Why?
|
Mesentery | 1 | 2013 | 202 | 0.030 |
Why?
|
Methotrexate | 2 | 2012 | 1719 | 0.020 |
Why?
|
Regression Analysis | 1 | 2002 | 6345 | 0.020 |
Why?
|
Syndrome | 1 | 1998 | 3267 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2417 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3156 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1998 | 1301 | 0.020 |
Why?
|
Prospective Studies | 4 | 2021 | 54423 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6484 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4544 | 0.020 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 42 | 0.020 |
Why?
|
Acute Disease | 1 | 2002 | 7237 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3384 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2568 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2002 | 1896 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 534 | 0.020 |
Why?
|
Risk | 1 | 2002 | 9610 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 74213 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10090 | 0.020 |
Why?
|
Odds Ratio | 1 | 2002 | 9647 | 0.020 |
Why?
|
Telomere | 1 | 2015 | 943 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1998 | 1881 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7406 | 0.020 |
Why?
|
Estrogens | 1 | 2016 | 1522 | 0.020 |
Why?
|
Nausea | 1 | 2012 | 679 | 0.020 |
Why?
|
Bradycardia | 1 | 2011 | 299 | 0.020 |
Why?
|
Radiometry | 1 | 2014 | 813 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5870 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 651 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1652 | 0.020 |
Why?
|
Growth Plate | 1 | 2010 | 274 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2643 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21019 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1638 | 0.020 |
Why?
|
Femur Head | 1 | 2010 | 297 | 0.020 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 41 | 0.020 |
Why?
|
Pelvic Bones | 1 | 2010 | 270 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12059 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4542 | 0.020 |
Why?
|
Celiac Disease | 1 | 2016 | 821 | 0.020 |
Why?
|
Pain | 1 | 2003 | 5073 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11122 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2015 | 1189 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 41495 | 0.020 |
Why?
|
Testis | 1 | 2010 | 794 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 409 | 0.020 |
Why?
|
Neutropenia | 1 | 2012 | 885 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 2013 | 711 | 0.020 |
Why?
|
Anemia | 1 | 2016 | 1509 | 0.020 |
Why?
|
Appendicitis | 1 | 2013 | 675 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3929 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3617 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 39969 | 0.020 |
Why?
|
Neuralgia | 1 | 2012 | 615 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4176 | 0.020 |
Why?
|
Testosterone | 1 | 2016 | 2472 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5821 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2915 | 0.020 |
Why?
|
Procarbazine | 1 | 2004 | 172 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3578 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.010 |
Why?
|
Urinary Bladder | 1 | 2010 | 1152 | 0.010 |
Why?
|
Parents | 1 | 2018 | 3563 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3826 | 0.010 |
Why?
|
Thoracic Surgical Procedures | 1 | 2008 | 350 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13381 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1265 | 0.010 |
Why?
|
Risk Assessment | 2 | 2021 | 23996 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4652 | 0.010 |
Why?
|
Aged | 2 | 2008 | 169310 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4915 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2422 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3415 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2539 | 0.010 |
Why?
|
Middle Aged | 2 | 2008 | 220921 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2000 | 26202 | 0.010 |
Why?
|
United States | 2 | 2021 | 72340 | 0.010 |
Why?
|
Defective Viruses | 1 | 1978 | 89 | 0.010 |
Why?
|
DNA, Circular | 1 | 1978 | 97 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2002 | 1039 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2820 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2002 | 865 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13367 | 0.010 |
Why?
|
Cattle | 1 | 2002 | 3849 | 0.010 |
Why?
|
Pneumonia | 1 | 2008 | 2143 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13642 | 0.010 |
Why?
|
Simplexvirus | 1 | 1978 | 803 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 4021 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11076 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9032 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6075 | 0.010 |
Why?
|
Patient Compliance | 1 | 2002 | 2690 | 0.010 |
Why?
|
DNA, Viral | 1 | 1978 | 2202 | 0.010 |
Why?
|
Base Sequence | 1 | 2002 | 12441 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10766 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14665 | 0.000 |
Why?
|
Molecular Weight | 1 | 1978 | 2186 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1978 | 2561 | 0.000 |
Why?
|
Virus Replication | 1 | 1978 | 2435 | 0.000 |
Why?
|
Animals | 1 | 2002 | 168475 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1978 | 2910 | 0.000 |
Why?
|
Cell Line | 1 | 1978 | 15601 | 0.000 |
Why?
|